The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.

Key Challenges

Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.

Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

Erbitux (cetuximab) - February 2016
Rituxan (rituximab) - September 2016
Herceptin (trastuzumab) - June 2019
Avastin (bevacizumab) - July 2019
Aranesp (darbepoetin alfa) - May 2024
Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.View less

Specialty and Fine Chemicals

Cosmetic Ingredients

Food Ingredients

Aerospace and Defense

Automotive and Transportation

Consumer Electronics

Construction Engineering

Industrial Automation and Machinery

Semiconductors

Smart Technologies

Information and Communication Technology

Biotechnology Published Insights

Global Single Cell Omics Market

Published Date : Jan 2024

Single cell omics refers to the application of omics technologies to individual cells to obtain a comprehensive view of their molecular characteristics and behavior. The term "omics" encompasses several disciplines in molecular biology that include genomics, transcrip... View more

Global Animal Biotechnology Market

Published Date : Jan 2024

Animal biotechnology is the use of biological processes and systems in animals to develop or modify products and processes for specific use. It involves the genetic engineering and cloning of animals for producing new drugs and vaccines. The growing demand for livesto... View more

Global Sequencing Consumables Market

Published Date : Jan 2024

Sequencing consumables refer to the reagents, consumables, and kits used in next-generation sequencing (NGS) technologies. Next-generation sequencing has revolutionized genomic research and clinical diagnostics in recent years by allowing large-scale, fast, and low-co... View more

Global Antisense Rnai Therapeutics Market

Published Date : Jan 2024

Antisense & RNAi therapeutics refer to a class of drugs that use naturally occurring processes to target and inhibit the expression of specific genes. They work by binding to mRNA or genomic DNA with high specificity. This inhibits the expression of disease-associ... View more

Global Consumer Genomics Market

Published Date : Jan 2024

Direct-to-consumer genetic tests (DTC-GT) are genetic tests sold directly to consumers to provide information about their genetic information (generally ancestry, some health traits, and health risks) from a saliva sample. Three main categories of genetic testing are ... View more

Platelet Concentration Systems Market

Published Date : Jan 2024

Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as pla... View more

Protein Sequencing Market

Published Date : Dec 2023

Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to determine the order of amino acids in a protein. This process helps in understanding the structure and function of proteins, which are essential in various biological ... View more

Spatial Genomics Transcriptomics Market

Published Date : Dec 2023

Spatial genomics transcriptomics refers to a set of advanced techniques that enable the simultaneous analysis of both the spatial distribution of genetic material (transcriptomics) and the physical context within biological tissues. This approach provides insights int... View more

Baculovirus Expression System Market

Published Date : Dec 2023

A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. Th... View more

3d Cell Culture Market

Published Date : Nov 2023

The Global 3d Cell Culture Market is estimated to be valued at US$ 4.89 Billion in 2023 and is expected to exhibit a CAGR of 23.4% during the forecast period (2023-2030). Analysts’ Views on the Global 3D Cell Culture Market: 3D cell culture refers to the cultivation of cells in an environmen... View more

Patient Derived Xenograft Model Market

Published Date : Nov 2023

The Patient Derived Xenograft Model Market size is expected to reach US$ 346 million by 2030, from US$ 105.4 million in 2023, at a CAGR of 18.5% during the forecast period. Patient-derived xenograft (PDX) models are developed by implanting patient tumor samples into immunodeficient mice. These model... View more

Escherichia Coli Strain Market

Published Date : Nov 2023

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastro... View more

Red Biotechnology Market

Published Date : Nov 2023

Global Red Biotechnology Market size is expected to reach US$ 1,513.22 Bn by 2030, from US$ 742.80 Bn in 2023, exhibiting a CAGR of 10.7% during the forecast period. Red biotechnology involves the use of biological agents or organisms in the manufacturing of biopharmaceutical drugs, genetically mod... View more

Flow Imaging Microscopy Analysis Market

Published Date : Nov 2023

Flow imaging microscopy analysis is a revolutionary technique that allows for the visualization and analysis of particles in a fluid sample. This technology offers a unique perspective on particle characterization, providing valuable insights for a wide range of appli... View more

Bioengineered Artificial Skin Market

Published Date : Nov 2023

Bioengineered skin is designed to undertake the functions of the epidermis and/or dermis as a temporary usage till the patient's skin barrier spontaneously repairs itself naturally. Bioengineered skin is used to address severe scars which represents the result of the ... View more

Marine Biotechnology Market

Published Date : Nov 2023

Marine biotechnology is the creation of products and processes from marine organisms through the application of biotechnology, molecular and cell biology, and bioinformatics. It is the field of science that deals with ocean exploration for development of new pharmaceutical drugs, chemical product... View more

Vaccine Technologies Market

Published Date : Nov 2023

Vaccine technology refers to the methods and strategies used to create vaccines. Vaccines are biological substances that can improve immunity to a particular disease. They prepare the body's immune system to fight off specific infections. Vaccine technologies have wit... View more

Humira Biosimilar Market

Published Date : Nov 2023

Humira is a biologic medication used to treat autoimmune conditions like psoriasis and rheumatoid arthritis and is the most popular biologic medication in the world. Following the expiration of patent protection for humira in some regions, biosimilars are highly simil... View more

Biotechnology Published Insights

Credibility and Certifications